| Display title | Chemistry:Ricasetron |
| Default sort key | Ricasetron |
| Page length (in bytes) | 4,486 |
| Namespace ID | 3022 |
| Namespace | Chemistry |
| Page ID | 323741 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Page image |  |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Steve Marsio |
| Date of page creation | 22:52, 23 October 2022 |
| Latest editor | imported>Steve Marsio |
| Date of latest edit | 22:52, 23 October 2022 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Ricasetron (BRL-46470) is a drug which acts as a selective antagonist at the serotonin 5-HT3 receptor. It has antiemetic effects as with other 5-HT3 antagonists, and also has anxiolytic effects significantly stronger than other related drugs, and with less side effects than benzodiazepine anxiolytics... |
